Cervical screening up 7% in England:
This article was originally published in Clinica
Laboratories in England have reported a 7% annual increase in cervical smear tests. Some 4.4 million samples, involving 3.9 million women of all ages, were screened under the National Health Service's programme in 2001-02. At the end of March 2002, 81.6% of eligible women aged 25-64 had been screened at least once in the previous five years. In 76 of the 99 health authorities the coverage was 80% or higher.
You may also be interested in...
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.